The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

New Study Contradicts ‘Experts’ – Shows Unvaccinated Adults Found “No increase in Myocarditis and Pericarditis” Following COVID Infection

Authors:  Jim Hoft July 8, 2022 Gateway Pundit A new study from Israel reveals that there was “no increase in the incidence of myocarditis and pericarditis” in unvaccinated adults who […]

Vaccinated Up to 15X MORE LIKELY Than Unvaxxed to Develop Heart Inflammation Requiring Hospitalization: Peer Reviewed Study

Authors:  Julian Conradson Published April 25, 2022 at 4:14pm A new study out of Europe has revealed that cases of heart inflammation that required hospitalization were much more common among vaccinated individuals […]

SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis

Authors: RALPH TURCHIANO   SEPTEMBER 8, 2021 •  Abstract Establishing the rate of post-vaccination cardiac myocarditis in the 12-15 and 16-17-year-old population in the context of their COVID-19 hospitalization risk is critical […]

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, […]

The Role of Colchicine in Pericardial Syndromes

Authors: George Lazaros 1, Massimo Imazio 2, Antonio Brucato 3, Charalambos Vlachopoulos 1, Emilia Lazarou 1, Dimitrios Vassilopoulos 4, Dimitris Tousoulis 1PMID: 29336245 DOI: 10.2174/1381612824666180116101823 Curr Pharm Des . 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823. Abstract Background: Colchicine is an old drug originally employed for the treatment of inflammatory disorders […]